COMMUNIQUÉS West-GlobeNewswire

Voyager Therapeutics to Present at Investor Conferences in November

13/11/2017 - 18:30

CAMBRIDGE, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company developing life-changing treatments for severe neurological diseases, today announced [...]

ADMA Biologics Announces Closing of $42M Follow-On Offering

13/11/2017 - 18:30

RAMSEY, N.J. and BOCA RATON, Fla., Nov. 13, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA ) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin [...]

Novartis canakinumab (ACZ885) reduced cardiovascular risk by 25% in subgroup of CANTOS Phase III trial participants

13/11/2017 - 18:01

Subgroup of patients had a 25% reduction in major adverse cardiovascular events when treated with canakinumab in a new analysis of Phase III CANTOS trial presented at the American Heart Association Scientific Sessions [...]

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...

13/11/2017 - 18:01

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

13/11/2017 - 18:01

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

ImmuCell Achieves USDA Approval of New Product Claim to Prevent Rotavirus Infections

13/11/2017 - 17:30

PORTLAND, Maine, Nov. 13, 2017 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC ), a growing animal health company that develops, manufactures and markets scientifically-proven products that improve the health and [...]

Ogilvy CommonHealth Worldwide’s Ritesh Patel Tapped to Speak at the 3rd Annual Mobile & Digital Platforms Summit for Life Sciences

13/11/2017 - 17:16

PARSIPPANY, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), the health behavior change specialists of Ogilvy & Mather ( www.ogilvy.com ) and a WPP Health & Wellness [...]

American Health Council Appoints Amy Allard AAS, BSN, MPH to Board of Nurses

13/11/2017 - 17:16

NEW YORK, Nov. 13, 2017 (GLOBE NEWSWIRE) -- The American Health Council is proud to appoint Administrative Director Amy Allard BSN, MPH, RN to its Nursing Board. With an extensive 40 years as a healthcare provider in [...]

Ossur Hf : Transactions in relation to share buyback program

13/11/2017 - 17:01

Announcement from Össur hf. No. 82/2017 Reykjavík, 13 November 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

IQVIA Institute Rates WellDoc’s BlueStar® as “Top App” in Clinical Diabetes Treatment

13/11/2017 - 16:52

COLUMBIA, Md., Nov. 13, 2017 (GLOBE NEWSWIRE) -- WellDoc®, a leading digital health company, announced today that IQVIA Institute for Human Data Science (formerly Quintiles/IMS) named BlueStar®, WellDoc’s FDA-cleared, [...]

NewLink Genetics to Participate in November Investor Conferences

13/11/2017 - 16:30

AMES, Iowa, Nov. 13, 2017 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) will participate in the following investor conferences this week: Stifel 2017 Healthcare Conference on Tuesday, November 14 th [...]

Immunomedics Announces Presentations and Investor Event at the 2017 San Antonio Breast Cancer Symposium

13/11/2017 - 15:30

MORRIS PLAINS, N.J., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that two of its abstracts were posted online at www.abstracts2view.com/sabcs/ [...]

Biothera Pharmaceuticals Presents Data Broadening Imprime PGG Mechanism of Action

13/11/2017 - 15:30

Reduces expression of IDO, a potent suppressor of an anti-cancer T cell response Supplementation with IVIG boosts biomarker levels, restoring Imprime-driven pharmacodynamic responses EAGAN, Minn., Nov. 13, 2017 (GLOBE [...]

Uptick Newswire's “Stock Day” News Program Interviews New Proposed Joint Venture Partner of Skyline Medical Inc.

13/11/2017 - 15:30

Phoenix, AZ, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Uptick Newswire's "Stock Day" today announced that it has interviewed Gerald Vardzel, CEO of Helomics Corp., the planned joint venture partner of Skyline Medical (SKLN). [...]

Micron Solutions, Inc. Reports 2017 Third Quarter Results

13/11/2017 - 15:19

FITCHBURG, Mass., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]

MRI Interventions ClearPoint® Neuro Navigation System to be Featured at SNO/SCIDOT Joint Conference on Therapeutic Delivery to the CNS

13/11/2017 - 15:00

IRVINE, Calif., Nov. 13, 2017 (GLOBE NEWSWIRE) -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint ® Neuro Navigation System will be on display at the Society for Neuro-Oncology (SNO) and the [...]

Galectin Therapeutics CEO Peter G. Traber, M.D. Named Chair of the Anti-Fibrotic Drug Development Summit 2017

13/11/2017 - 15:00

NORCROSS, Ga., Nov. 13, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT ), the leading developer of therapeutics that target galectin proteins, announced that Peter G. Traber, M.D., the Company's chief [...]

CEO Kym Anthony Discusses 2017 Miles Stones and Product Developments

13/11/2017 - 15:00

Ottawa, ONT , Nov. 13, 2017 (GLOBE NEWSWIRE) -- Kym Anthony CEO of Avivagen, Inc. (“Company”) (TSX-V: VIV ), (OTCPink: CHEXF ) interviews with host Everett Jolly on the Uptick Network Stock Day Podcast. In the first [...]

Cytori Announces New U.S. Investigator Trial for Hip Osteonecrosis

13/11/2017 - 15:00

SAN DIEGO, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (Nasdaq: CYTX ) (“Cytori” or “the Company”) today announced a new investigator initiated U.S. clinical trial for hip osteonecrosis. Details of the [...]